Philip N. Murphy

2.4k total citations · 1 hit paper
70 papers, 1.7k citations indexed

About

Philip N. Murphy is a scholar working on Clinical Psychology, Toxicology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Philip N. Murphy has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Psychology, 17 papers in Toxicology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Philip N. Murphy's work include Forensic Toxicology and Drug Analysis (17 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Substance Abuse Treatment and Outcomes (11 papers). Philip N. Murphy is often cited by papers focused on Forensic Toxicology and Drug Analysis (17 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Substance Abuse Treatment and Outcomes (11 papers). Philip N. Murphy collaborates with scholars based in United Kingdom, Ireland and United States. Philip N. Murphy's co-authors include John E. Fisk, Michelle Wareing, Catharine Montgomery, K. J. Gilhooly, Hugh Garavan, Timothy M. Clough, Gus A. Baker, Paul Hutton, Marylène Cloître and Aoife Bradley and has published in prestigious journals such as PLoS ONE, Physics Letters B and Psychological Medicine.

In The Last Decade

Philip N. Murphy

69 papers receiving 1.6k citations

Hit Papers

Psychological interventions for ICD-11 complex PTSD sympt... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip N. Murphy United Kingdom 24 595 428 391 321 262 70 1.7k
Andy C. Dean United States 22 218 0.4× 75 0.2× 611 1.6× 153 0.5× 261 1.0× 47 1.6k
Jane H. Powell United Kingdom 16 229 0.4× 90 0.2× 209 0.5× 82 0.3× 230 0.9× 20 1.9k
Helge Müller Germany 18 290 0.5× 65 0.2× 92 0.2× 132 0.4× 83 0.3× 76 1.4k
Harry Klonoff Canada 22 154 0.3× 35 0.1× 93 0.2× 176 0.5× 157 0.6× 61 1.8k
Sarah Hartley France 20 143 0.2× 27 0.1× 71 0.2× 153 0.5× 329 1.3× 86 1.1k
Janet H. Potvin United States 24 477 0.8× 11 0.0× 236 0.6× 809 2.5× 306 1.2× 42 2.4k
Dongmei An China 27 249 0.4× 51 0.1× 242 0.6× 269 0.8× 189 0.7× 98 2.3k
Daniel Amen United States 22 393 0.7× 8 0.0× 141 0.4× 121 0.4× 134 0.5× 68 1.7k
Jeffrey P. Reiss Canada 23 319 0.5× 11 0.0× 80 0.2× 79 0.2× 410 1.6× 42 1.4k
M Mumenthaler United States 18 71 0.1× 12 0.0× 176 0.5× 131 0.4× 223 0.9× 87 1.7k

Countries citing papers authored by Philip N. Murphy

Since Specialization
Citations

This map shows the geographic impact of Philip N. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip N. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip N. Murphy more than expected).

Fields of papers citing papers by Philip N. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip N. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip N. Murphy. The network helps show where Philip N. Murphy may publish in the future.

Co-authorship network of co-authors of Philip N. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip N. Murphy. A scholar is included among the top collaborators of Philip N. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip N. Murphy. Philip N. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gouvernet, Brice, et al.. (2022). Le modèle alternatif des troubles de la personnalité en population française : évaluation avec des outils brefs. L Encéphale. 49(5). 496–503. 1 indexed citations
4.
Murphy, Philip N., Michelle Wareing, John W. McNeill, et al.. (2018). High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns. Journal of Substance Abuse Treatment. 92. 91–98. 2 indexed citations
5.
Murphy, Philip N., et al.. (2017). Results of enhanced recovery after primary ankle replacements. The Foot. 31. 13–15. 2 indexed citations
6.
Murphy, Philip N., et al.. (2015). Acceptance and Commitment Therapy in the Treatment of Alcohol Use Disorder and Comorbid Affective Disorder: A Pilot Matched Control Trial. Behavior Therapy. 46(6). 717–728. 32 indexed citations
7.
Murphy, Philip N., et al.. (2014). Why do medical trainees take time out of their specialty training programmes?. British Journal of Hospital Medicine. 75(10). 584–589. 8 indexed citations
8.
Brown, Jeremy, et al.. (2014). An investigation into the use of multi-source feedback (MSF) as a work-based assessment tool. Medical Teacher. 36(11). 997–1004. 12 indexed citations
9.
Kumar, Vishwajeet, et al.. (2013). Are albumin and total lymphocyte count significant and reliable predictors of mortality in fractured neck of femur patients?. European Journal of Orthopaedic Surgery & Traumatology. 24(7). 1193–1196. 12 indexed citations
10.
Kumar, Vishwajeet, Timothy M. Millar, Philip N. Murphy, & T.M. Clough. (2013). The treatment of intractable plantar fasciitis with platelet-rich plasma injection. The Foot. 23(2-3). 74–77. 47 indexed citations
11.
Brown, Jeremy, et al.. (2012). The training needs and career intentions of staff grade and associate specialist doctors. British Journal of Hospital Medicine. 73(9). 521–525. 3 indexed citations
12.
Montgomery, Catharine, John E. Fisk, Michelle Wareing, & Philip N. Murphy. (2007). Self reported sleep quality and cognitive performance in ecstasy users. Human Psychopharmacology Clinical and Experimental. 22(8). 537–548. 23 indexed citations
13.
Fisk, John E., Catharine Montgomery, Michelle Wareing, & Philip N. Murphy. (2006). The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?. Human Psychopharmacology Clinical and Experimental. 21(6). 355–366. 15 indexed citations
14.
Wareing, Michelle, John E. Fisk, Philip N. Murphy, & Catharine Montgomery. (2005). Visuo-spatial working memory deficits in current and former users of MDMA (?ecstasy?). Human Psychopharmacology Clinical and Experimental. 20(2). 115–123. 27 indexed citations
15.
Murphy, Philip N., et al.. (2005). Does alexithymia differentiate between patients with nonepileptic seizures, patients with epilepsy, and nonpatient controls?. Epilepsy & Behavior. 7(3). 430–437. 82 indexed citations
16.
Wareing, Michelle, Philip N. Murphy, & John E. Fisk. (2004). Visuospatial memory impairments in users of MDMA (?ecstasy?). Psychopharmacology. 173(3-4). 391–397. 45 indexed citations
17.
Fisk, John E., Catharine Montgomery, Philip N. Murphy, & Michelle Wareing. (2004). Evidence for executive deficits among users of MDMA (Ecstasy). British Journal of Psychology. 95(4). 457–466. 35 indexed citations
18.
Murphy, Philip N., et al.. (2003). Predicting postdischarge opiate abstinence from admission measures of motivation and confidence.. Psychology of Addictive Behaviors. 17(2). 167–170. 5 indexed citations
19.
Wareing, Michelle, John E. Fisk, & Philip N. Murphy. (2000). Working memory deficits in current and previous users of MDMA (‘ecstasy’). British Journal of Psychology. 91(2). 181–188. 150 indexed citations
20.
Murphy, Philip N. & Richard P. Bentall. (1992). Motivation to withdraw from heroin: a factor‐analytic study. British Journal of Addiction. 87(2). 245–250. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026